Peter Kaiser

19PUBLICATIONS
59CO-AUTHORS
SurgeryGene and molecular therapyEpidemiological modellingVision scienceNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Apr 21, 2026
Quality Improvement in Vitreoretinal Surgery: Single-Center Report on Utility of Routine Intravenous Fluids in Pars Plana Vitrectomy.

|Dec 18, 2025
TALON phase IIIb study: 64 week results of brolucizumab versus aflibercept using treat-and-extend for neovascular age-related macular degeneration.

Carl Regillo, Peter K Kaiser, Peter J Kertes

|Oct 07, 2025
Real-World Functional and Anatomic Outcomes With Aflibercept 8.0 mg in Patients With Diabetic Macular Edema.

Gabriel Castilho S Barbosa, Suraj Bala, Nitesh Mohan

|Aug 25, 2025
Impact of Central Subfield Thickness Fluctuations on Visual Outcomes in Neovascular Age-Related Macular Degeneration in the VIEW Trials.

Dilsher S Dhoot, Chirag P Shah, Fabiana Q Silva

|Nov 14, 2024
Imaging-Guided Classification of Neovascularization in Neovascular Age-Related Macular Degeneration: Progress to Date.

Giovanni Staurenghi, Eric H Souied, Tomohiro Iida

|Aug 26, 2024
Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI).

Ashish Sharma, Peter K Kaiser, Ramin Tadayoni

Pageof 4

Frequent Collaborators

4 joint publications

Varun Chaudhary

3 joint publications

Nilesh Kumar

3 joint publications

Ashish Sharma

2 joint publications

Danny A Mammo